ENTITY
Peptidream Inc

Peptidream Inc (4587 JP)

26
Analysis
Health CareJapan
PeptiDream Inc. is a biopharmaceutical company that researches and develops peptide therapeutics to improve the life of patients.
more
Refresh
bullishPeptidream Inc
09 Sep 2023 00:54

Peptidream (4587 JP): Solid Revenue Growth Continued in 1H23; 2023 Guidance Remains Unchanged

In 1H23, revenue jumped 88% YoY, and both the operating and net losses have narrowed compared with 1H22. 2023 guidance calls for a 12% YoY revenue...

Logo
478 Views
Share
bullishPeptidream Inc
17 May 2023 18:20

Peptidream (4587 JP): 1Q23 Result- Radiopharma Drove Sales; Losses Narrowed; Guidance Reiterated

Peptidream recorded ¥5B revenue in 1Q23. While base business revenue jumped 133% YoY, acquired radiopharma contributed ¥4B revenue. Compared with...

Logo
205 Views
Share
bullishPeptidream Inc
03 Jan 2023 23:52

Peptidream (4587 JP): Rising Drug Discovery Collaborations To Drive Growth; New Revenue Stream Added

In long-term, Peptidream targets ¥100B revenue from ¥9.4B in 2021. While base business is poised for steady growth via expansion of collaboration...

Logo
418 Views
Share
28 Dec 2022 00:00

Ono Pharmaceutical (4528 JP): Key Drugs On High Growth Trajectory; Pipeline Expands Beyond Opdivo

Driven by indication expansion, Ono expects Opdivo sales to reach ¥155B in FY23, up 38% y/y. The company is developing clinical pipeline beyond...

Logo
779 Views
Share
bearishRakus Co Ltd
27 Jul 2022 20:15

JPX-Nikkei 400 2022 Rebal: Final Pre-Event Phase Strategy Worked. What Next?

The official index changes could be announced on 5th August 2022. Expect some positive and negative surprises. Inclusion/Exclusion events could...

Share
x